Editorial

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is such an innovative medicine, that it seems like something straight out of a science fiction novel. This gene editing technology allows scientists to precisely target spots in our DNA to fix mutations or stop disease-ridden parts

We haven’t stepped that deep into the 21st century, but we have already witnessed how a microscopic organism like a virus can wreak havoc. They evolve to become more resistant to our usual remedies so we have to escape them in a biological race on an atomic level. Consequently, scientists have come

Annual drug shortages are common in the US and indeed throughout the world and can be attributed to a few key issues. Experts have pointed out how policy can assist in regulating the production, manufacturing, distribution, and purchase of essential drugs to prevent shortages of critical drugs,

The two companies leading the charge in integrating human physiology with machinery, Neuralink and Synchron, have both entered the human clinical trials stage of research and development. Both companies aim to improve and eventually restore patients’ mobility, filling the unmet medical needs of m

The pharmaceutical world is a key foundation of modern medicine. It offers critical treatments that help millions survive globally, as well as improve their standards of living. Nevertheless, underneath all these major advantages lies an unclear issue that affects both patients and healthcare

Elon Musk. Jeff Bezos. Bill Gates. These three men have a lot in common. They’re all tech founders who have disrupted their respective industries and cemented their place in the annals of history for their global (and extra-terrestrial) dominance. Between them, they have a combined net worth of j